Pricing Log in Create free account

Curis, Inc. (CRIS) vs Exicure, Inc. (XCUR)

Curis, Inc. and Exicure, Inc. are both Biotechnology companies. Curis, Inc. and Exicure, Inc. are of similar size ($5.8M and $5.7M). Exicure, Inc. grew revenue faster over the last twelve months: 2,366.5% against −13.4%. Across the 13 metrics below, Curis, Inc. leads on 7 and Exicure, Inc. on 6.

Valuation

Metric CRIS XCUR Biotechnology median
P/E n/m n/m 10.60
P/S 0.20 0.22 9.40
P/B 0.40 5.94 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.29 n/m 0.66
EV/Sales (0.27) 0.19 9.02
Earnings yield (1,615.91%) (145.05%) (32.88%)
Free cash flow yield (1,649.45%) (102.61%) (23.13%)

Profitability

Metric CRIS XCUR Biotechnology median
Gross margin 99.52% 80.08% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 455.35% (168.37%) (51.96%)
Return on assets (87.76%) (54.98%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRIS XCUR Biotechnology median
Revenue growth (TTM) (13.43%) 2,366.45% 6.76%
EPS growth (last fiscal year) 91.57% 83.37% 29.88%
Revenue growth, 5-year CAGR (2.71%) 33.48% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRIS XCUR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.49 0.56 4.97
Net debt to EBITDA 0.91 0.99 1.01

Dividend

Metric CRIS XCUR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CRIS XCUR Biotechnology median
Market cap 5.67m 5.83m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack